Clinical Trials


Broward Health's clinical trials program focuses on finding better ways to treat illnesses through a voluntary program between patients and their doctors. A clinical trial is a research study where individuals receive investigational treatments under the supervision of a physician and other research professionals.

Clinical Trials

Broward Health's clinical trials program focuses on finding better ways to treat illnesses through a voluntary program between patients and their doctors. A clinical trial is a research study where individuals receive investigational treatments under the supervision of a physician and other research professionals.

What Are Clinical Trials?

Broward Health has a variety of Active Adult and Pediatric Clinical Trials available on a continual basis, which may include medical research using investigational devices or participation in a clinical drug trial for the treatment of heart disease, cancer, HIV/AIDS, memory disorders, traumatic brain injury, and other diseases.

Clinical trials are studies in which people volunteer to take part in tests of new drugs or procedures. Doctors use clinical trials to develop new treatments for serious diseases, such as cancer. For those individuals who do participate in a clinical trial, they may have an opportunity to benefit from a new treatment that not might otherwise have been known. You may learn more about clinical trials by visiting ClinicalTrials.gov.

Current Studies at Broward Health

Clinical trials are studies in which people volunteer to take part in tests of new drugs or procedures. Doctors use clinical trials to develop new treatments for serious diseases, such as cancer. You may learn more about clinical trials by visiting ClinicalTrials.gov

PEDIATRIC CANCER TRIALS 

  • Leukemia
    • AALL1131: A Children’s Oncology Protocol for Combination Chemotherapy in Treating Young Patients with Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
    • AALL1331: A Children’s Oncology Protocol for Blinatumomab in Treating Younger Patients with Relapsed B-cell Acute Leukemia
  • Brain & Spine
    • ACNS08B1: A Children’s Oncology Group Protocol for Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients with Newly Diagnosed Ependymoma
  • Liver
    • AHEP0731: A Children’s Oncology Group Protocol for Risk-Based Therapy in Treating Younger Patients with Newly Diagnosed Liver Cancer
  • Neuroblastoma
    • ANBL00B1: A Children’s Oncology Group Protocol for Biomarkers in Tumor Tissue Samples from Patients with Newly Diangosed Neuroblastoma or Ganglioneuroblastoma
    • ANBL1232: A Children’s Oncology Group Protocol for Response and Biology-Based Risk Factor Guided Therapy in Treating Younger Patients with Non-High Risk Neuroblastoma
  • Renal/Kidney
    • AREN03B2: A Children’s Oncology Group Protocol for Study of Kidney Tumors in Younger Patients
  • Other
    • ALTE05N1: A Children’s Oncology Protocol for Long-Term Follow-Up of Patients Who Have Participated in COG Studies
    • ACCRN07: Protocol for the Enrollment on the Official COG Registry, the Childhood Cancer Research Network (CCRN)
    • AHOD1331: A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35, IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults

ADULT CANCER RESEARCH TRIALS

  • Breast
    • Alliance A011401: Randomized Phase III Trail Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
    • Alliance A011502: A Randomized Phase III Double Blinded Placebo Controlled Trial Of Aspirin As Adjuvant Therapy For Node Positive HER2 Negative Breast Cancer: The ABC Trial
    • MT Group: Translational Medicine: Discovery and Evaluation of Biomarkers/Pharmacogenomics for the Diagnosis and Personalized Management of Patients
      • o Non-Small Cell Lung Cancer (NSCLC) MT0217
      • Colon Cancer MT0027
      • Melanoma or Non-Small Cell Lung MT0033
      • Renal Cell Carcinoma (RCC) MT0270
      • MT Group Fresh Tissue Request
    • SWOG S1207: A Phase III Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- hemotherapy in Patients Hormone Receptor-Positive and HER2-Negative Breast Cancer
    • SWOG S1501: Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic Her2+ Breast Cancer
  • Colon 
    • Array-818-302: A Multi-center, Randomized, Open-label, 3-Arm Phase 3 Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid FA)/Irinotecan (FOLFIRI)/Cetuximab in Patients with BRAF V600E-mutant Metastatic Colorectal Cancer
  • MDS/AML
    • Connect MDS/AML Disease Registry: Connect MDS and AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry. Open to Enrollment
  • Head & Neck
    • Soligenix IDR-OM-02: A Pivotal, Double-Blind, Randomized, Placebo-Controlled, Multinational Study of Sgx942 (Dusquetide) for the Treatment of Oral Mucositis in Patients Being Treated With Concomitant Chemoradiation for the Treatment of Squamous Cell Carcinoma of the Head and Neck

CARDIOVASCULAR RESEARCH

  • Topera: Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With Focal Impulse and Rotor Modulation Guided Procedures (REDO-FIRM)
  • St. Jude AMPLATZER™ Amulet™: Left Atrial Appendage (LAA) Occluder Trial (Amulet IDE)

Contact Us

Email Icon Email: BHResearch@browardhealth.org

Phone Icon Phone: 954-712-2983

Find a Doctor

We can match you to a doctor based on your location, language preference, and more. The search results will provide more ways to narrow your search.

Available At